Pipeline™ Embolization Device for the Treatment of Complex Intracranial Aneurysms
As part of its Medical Technologies Evaluation Programme, the National Institute of Health and Clinical Excellence (NICE) invited the manufacturer, Covidien, to provide clinical and economic evidence for the evaluation of the Pipeline™ embolization device (PED) for the treatment of complex intracranial aneurysms. Cedar; a consortium between Cardiff and Vale University Health Board and Cardiff University, was commissioned to act as an External Assessment Centre (EAC) for NICE to independently critique the manufacturers’ submissions. This article gives an overview of the evidence provided, the findings of the EAC and the final guidance published by NICE.
The scope issued by NICE considered PED as the intervention in a patient population with complex unruptured intracranial aneurysms (IAs), specifically large/giant, wide-necked and fusiform aneurysms. The comparator treatments identified were stent-assisted coiling, parent vessel occlusion, neurosurgical techniques and conservative management. The manufacturer claimed that PED fulfils a currently unmet clinical need in the treatment of large or giant, wide-necked or fusiform IAs.
Thirteen studies were identified by the manufacturer as being relevant to the decision problem, with two of these included for data extraction. The EAC identified 16 studies as relevant, three of which had been published after the manufacturer’s search. Data extraction was carried out on these studies as, although many were low level research comprising of case reports and case series, they provided useful, pertinent safety and outcome data.
No relevant economic studies of the device were identified; therefore, a new economic model was designed by the manufacturer. The base-case scenario provided recognized the costs of PED to be higher than the costs for endovascular parent vessel occlusion, neurosurgical parent vessel occlusion, neurosurgical clipping and conservative management. However, PED was found to be cost saving compared with stent-assisted coiling, with a saving of £13,110 per patient.
Analysis of the clinical data suggested that treatment with PED has high rates of clinical success with high rates of aneurysm occlusion and acceptable adverse events for the patient population. Economic evidence suggested that the costs in the base-case for PED may have been underestimated, meaning that PED would only become cost saving in patients who would otherwise require treatment with 32 coils or more. NICE Medical Technologies Guidance MTG10, issued in May 2012, recommends the adoption of PED in selected patients within the UK National Health Service (NHS).
- White J, Carolan-Rees G. PleurX peritoneal catheter drainage system for vacuum-assisted drainage of treatment-resistant, recurrent malignant ascites: a NICE medical technology guidance. Appl Health Econ Health Policy. 2012;10(5):299–308.
- Campbell B, Campbell M. NICE medical technologies guidance: a novel and rigorous methodology to address a new health technology assessment challenge. Appl Health Econ Health Policy. 2012;10(5):295–7.
- Vlak MH, Algra A, Brandenburg R, et al. Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. Lancet Neurol. 2011;10(7):626–36. CrossRef
- Burns JD, Brown RD Jr. Treatment of unruptured intracranial aneurysms: surgery, coiling, or nothing? Curr Neurol Neurosci Rep. 2009;9(1):6–12. CrossRef
- Unruptured intracranial aneurysms: risk of rupture and risks of surgical intervention. International Study of Unruptured Intracranial Aneurysms Investigators. N Eng J Med. 1998;339(24):1725–33.
- Molyneux AJ, Kerr RSC, Yu LM, et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet. 2005;366(9488):809–17. CrossRef
- Gonzalez NR, Duckwiler G, Jahan R, et al. Challenges in the endovascular treatment of giant intracranial aneurysms. Neurosurgery. 2006;59(5 Suppl. 3):S113–24.
- FDA. Chestnut Medical Technologies. Pipeline embolization device executive summary P100018. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/NeurologicalDevicesPanel/UCM247160.pdf. Accessed 2011 Sep 6.
- Nelson PK, Lylyk P, Szikora I, et al. The pipeline embolization device for the intracranial treatment of aneurysms trial. Am J Neuroradiol. 2011;32(1):34–40.
- Fiorella D, Woo HH, Albuquerque FC, et al. Definitive reconstruction of circumferential, fusiform intracranial aneurysms with the pipeline embolization device. Neurosurgery. 2008;62(5):1115–20. CrossRef
- Fiorella D, Kelly ME, Albuquerque FC, et al. Curative reconstruction of a giant midbasilar trunk aneurysm with the pipeline embolization device. Neurosurgery. 2009;64(2):212–7. CrossRef
- Fiorella D, Hsu D, Woo HH, et al. Very late thrombosis of a pipeline embolization device construct: case report. Neurosurgery. 2010;67(3):E313–4.
- Hartmann M, Rohde S, Braun C, et al. Endovascular treatment of cerebral aneurysms with the pipeline embolization device. Proceedings of the Jahrestagung der Deutschen Gesellschaft fur Neuroradiologie; 2010 Sep 22–25; Mannheim, Germany. Clin Neuroradiol. 2010; 20(3):190–1.
- Klisch J, Turk A, Turner R, et al. Very late thrombosis of flow-diverting constructs after the treatment of large fusiform posterior circulation aneurysms. Am J Neuroradiol. 2011;32(4):627–32. CrossRef
- Lylyk P, Miranda C, Ceratto R, et al. Curative endovascular reconstruction of cerebral aneurysms with the pipeline embolization device: the Buenos Aires experience. Neurosurgery. 2009;64(4):632–42. CrossRef
- Matouk C, O’Kelly C, Ellis M, et al. Pipeline embolization device reconstruction of ruptured intracranial aneurysms: report of two cases. In: Proceedings of the 45th Annual Congress of the Canadian Neurological Sciences Federation; 2010 Jun 8–11; Quebec, Canada. Can J Neurol Sci. 2010;37(3 Suppl. 1):S88–9.
- Phillips T, Mitchell P, Dowling R, et al. Endovascular treatment of intracranial aneurysms with new generation flow diverting stents: early experience in an Australian neurointerventional centre. In: Proceedings of the 61st Annual Scientific Meeting of the Royal Australian and New Zealand College of Radiologists; 2010 Oct 14–17; Perth, Australia. J Med Imag Radiat Oncol; 2010 Oct; 54(Suppl. 1):A122.
- Szikora I, Berentei Z, Kulcsar Z, et al. Effect of flow modification on aneurysm induced mass effect. In: Proceedings of the 19th Symposium Neuroradiologicum: The World Congress of Diagnostic and Therapeutic Neuroradiology; 2010 Oct 4–9; Bologna, Italy. Neuroradiol J 2010;23(1):324.
- Szikora I, Berentei Z, Kulcsar Z, et al. Treatment of intracranial aneurysms by functional reconstruction of the parent artery: the Budapest experience with the pipeline embolization device. Am J Neuroradiol. 2010;31(6):1139–47. CrossRef
- van Rooij WJ, Sluzewski M. Perforator infarction after placement of a pipeline flow-diverting stent for an unruptured A1 aneurysm. Am J Neuroradiol. 2010;31(4):E43–4. CrossRef
- Fiorella D, Albuquerque F, Gonzalez F, et al. Reconstruction of the right anterior circulation with the Pipeline embolization device to achieve treatment of a progressively symptomatic, large carotid aneurysm. J NeuroIntervent Surg. 2009;2(1):31–7. CrossRef
- Hampton T, Walsh D, Tolias C, et al. Mural destabilization after aneurysm treatment with a flow-diverting device: a report of two cases. J NeuroIntervent Surg. 2011;3(2):167–71. CrossRef
- O’Kelly C, Spears J, Chow M, et al. Canadian experience with the pipeline embolization device for repair of unruptured intracranial aneurysms. In: Proceedings of the 46th Annual Congress of the Canadian Neurological Sciences Federation; 2011 Jun 15–17; Vancouver, Canada. Can J Neurol Sci. 2011;38(3):S31.
- Sararols L, Castillo L, Graell X, et al. Right giant internal carotid artery bifurcation aneurism: presentation with homonymous left hemianopsia and successful treatment with intraneurismatic bypass. In: Proceedings of the 10th European Neuro-Ophthalmology Society; 2011 Jun 18–21; Barcelona Spain. Conference Publication; 35:S65.
- Wehman JC, Hanel RA, Levy EI, et al. Giant cerebral aneurysms: endovascular challenges. Neurosurgery. 2006;59(5):S125–38.
- Withers KL, Carolan-Rees G, Dale M, et al. External Assessment Centre report: Pipeline Embolisation Device for the treatment of complex intracranial aneurysms. http://www.nice.org.uk/nicemedia/live/13016/57154/57154.pdf. Accessed 2012 Sep 5.
- National Institute for Health and Clinical Excellence. Pipeline embolisation device for the treatment of complex intracranial aneurysms: NICE medical technology guidance 10. http://www.nice.org.uk/nicemedia/live/13685/59340/59340.pdf. Accessed 2012 Sep 5.
- Pipeline™ Embolization Device for the Treatment of Complex Intracranial Aneurysms
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
Applied Health Economics and Health Policy
Volume 11, Issue 1 , pp 5-13
- Cover Date
- Print ISSN
- Online ISSN
- Springer International Publishing AG
- Additional Links